Published in J Clin Lab Anal on January 01, 2009
DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur J Hum Genet (2010) 1.55
Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies. Lupus Sci Med (2016) 1.41
Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field. Placenta (2010) 1.09
Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease. EXS (2012) 1.03
Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. Cardiovasc Hematol Agents Med Chem (2010) 1.02
Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol (2015) 0.92
Matrix metalloproteinases as drug targets in preeclampsia. Curr Drug Targets (2013) 0.85
Increased expression of prostasin contributes to early-onset severe preeclampsia through inhibiting trophoblast invasion. J Perinatol (2014) 0.81
Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin deposition. Am J Physiol Heart Circ Physiol (2011) 0.81
Contribution of TIMP3 polymorphisms to the development of preeclampsia in Han Chinese women. J Assist Reprod Genet (2015) 0.75
Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia. Adv Pharmacol (2016) 0.75
Ratio of matrix metalloproteinase-2 to -9 is a more accurate predictive biomarker in women with suspected pre-eclampsia. Biosci Rep (2017) 0.75
Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy. Expert Opin Ther Targets (2015) 0.75
Decreased Homodimerization and Increased TIMP-1 Complexation of Uteroplacental and Uterine Arterial Matrix Metalloproteinase-9 during Hypertension-in-Pregnancy. Biochem Pharmacol (2017) 0.75
Increased Vascular and Uteroplacental Matrix Metalloproteinase-1 and -7 Levels and Collagen I Deposition in Hypertension-in-Pregnancy. Role of TNF. Am J Physiol Heart Circ Physiol (2017) 0.75
New Insights into the Role of Matrix Metalloproteinases in Preeclampsia. Int J Mol Sci (2017) 0.75
Trophoblast survival signaling during human placentation requires HSP70 activation of MMP2-mediated HBEGF shedding. Cell Death Differ (2017) 0.75
Efficacy of resveratrol to supplement oral nifedipine treatment in pregnancy-induced preeclampsia. Endocr Connect (2017) 0.75
Altered Maternal Serum Matrix Metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in Severe Early- and Late-Onset Preeclampsia. Biomed Res Int (2017) 0.75
Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia. Prog Mol Biol Transl Sci (2017) 0.75
Angiogenic Imbalance and Diminished Matrix Metalloproteinase-2 and -9 Underlie Regional Decreases in Uteroplacental Vascularization and Feto-placental Growth in Hypertensive Pregnancy. Biochem Pharmacol (2017) 0.75
PASS: a program to align short sequences. Bioinformatics (2009) 14.72
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst (2008) 6.13
Do clinicians decide relying primarily on Bayesians principles or on Gestalt perception? Some pearls and pitfalls of Gestalt perception in medicine. Intern Emerg Med (2014) 3.93
Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med (2009) 3.84
Acquired factor VIII inhibitors. Blood (2008) 2.67
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst (2003) 2.44
Biochemical markers of muscular damage. Clin Chem Lab Med (2010) 2.25
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) (2008) 2.23
Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med (2010) 2.20
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care (2007) 2.09
Circulating microRNAs (miRs) for diagnosing acute myocardial infarction: meta-analysis of available studies. Int J Cardiol (2012) 2.07
N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH. Rheumatol Int (2007) 2.03
Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM (2006) 2.01
Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med (2011) 2.01
Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med (2006) 1.85
Recommendations for detection and management of unsuitable samples in clinical laboratories. Clin Chem Lab Med (2007) 1.71
The order of draw: myth or science? Clin Chem Lab Med (2013) 1.66
The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful? Clin Chem Lab Med (2011) 1.65
Suitability of a transport box for blood sample shipment over a long period. Clin Biochem (2011) 1.64
Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department. Clin Chem Lab Med (2013) 1.63
Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med (2006) 1.60
Red blood cell distribution width is significantly associated with aging and gender. Clin Chem Lab Med (2014) 1.58
Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women. Circulation (2002) 1.57
Preanalytical phase--a continuous challenge for laboratory professionals. Biochem Med (Zagreb) (2012) 1.56
Development of a novel, hemolysis-resistant reagent for assessment of α-amylase in biological fluids. Clin Chem Lab Med (2013) 1.54
Laboratory medicine does matter in science (and medicine)… yet many seem to ignore it. Clin Chem Lab Med (2015) 1.53
Biomedical research platforms and their influence on article submissions and journal rankings: an update. Biochem Med (Zagreb) (2012) 1.53
Longitudinal umbilical vein blood flow changes in normal and growth-retarded fetuses. Acta Obstet Gynecol Scand (2002) 1.50
Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol (2008) 1.50
Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis (2006) 1.50
Postoperative variation of C-reactive protein and procalcitonin in patients with gastrointestinal cancer. Clin Lab (2009) 1.49
Acquired factor V inhibitors: a systematic review. J Thromb Thrombolysis (2011) 1.47
Should women with abnormal serum thyroid stimulating hormone undergo screening for anemia? Arch Pathol Lab Med (2008) 1.45
Together we care: new challenges for global haemophilia treatment centers. Indian J Med Res (2009) 1.44
Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci (2014) 1.44
New ways to deal with known preanalytical issues: use of transilluminator instead of tourniquet for easing vein access and eliminating stasis on clinical biochemistry. Biochem Med (Zagreb) (2011) 1.43
Iron and thrombosis. Ann Hematol (2007) 1.43
The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. Hypertension (2008) 1.42
Routine coagulation tests in newborn and young infants. J Thromb Thrombolysis (2007) 1.42
The baseline serum value of α-amylase is a significant predictor of distance running performance. Clin Chem Lab Med (2015) 1.42
The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med (2011) 1.42
Phlebotomy issues and quality improvement in results of laboratory testing. Clin Lab (2006) 1.41
Reliability of the thrombin-generation assay in frozen-thawed platelet-rich plasma. Clin Chem (2006) 1.40
The health risks of acute exercise should also matter to internal medicine. Eur J Intern Med (2011) 1.40
Is laboratory medicine a dying profession? Blessed are those who have not seen and yet have believed. Clin Biochem (2010) 1.40
Reduction of unsuitable specimens: a more radical and comprehensive approach is needed. Clin Chim Acta (2010) 1.39
Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE). Clin Chem Lab Med (2015) 1.39
The growing impact of publications in haemostasis and thrombosis journals. Thromb Haemost (2007) 1.38
Antenatal care in developing countries: the need for a tailored model. Semin Fetal Neonatal Med (2005) 1.36
Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes. J Diabetes (2012) 1.31
Survey of national guidelines, education and training on phlebotomy in 28 European countries: an original report by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working group for the preanalytical phase (WG-PA). Clin Chem Lab Med (2013) 1.31
Quality standards for sample collection in coagulation testing. Semin Thromb Hemost (2012) 1.29
Vitamin D, thrombosis, and hemostasis: more than skin deep. Semin Thromb Hemost (2012) 1.28
Prothrombin complex concentrates: an update. Blood Transfus (2010) 1.27
Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients. Scand J Clin Lab Invest (2008) 1.25
The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis (2010) 1.24
Biological variation and reference change values: an essential piece of the puzzle of laboratory testing. Clin Chem Lab Med (2012) 1.22
Laparoscopic radiofrequency thermal ablation: a new approach to symptomatic uterine myomas. Am J Obstet Gynecol (2005) 1.21
Risk management in the preanalytical phase of laboratory testing. Clin Chem Lab Med (2007) 1.20
Mean platelet volume increases with aging in a large population study. Thromb Res (2012) 1.20
The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass. J Clin Lab Anal (2009) 1.20
ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci (2012) 1.20
Impact of the phlebotomy training based on CLSI/NCCLS H03-a6 - procedures for the collection of diagnostic blood specimens by venipuncture. Biochem Med (Zagreb) (2012) 1.20
Acquired factor VIII inhibitors in oncohematology: a systematic review. Crit Rev Oncol Hematol (2008) 1.19
Laboratory, clinical and therapeutic aspects of acquired hemophilia A. Clin Chim Acta (2008) 1.19
Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin Chem Lab Med (2009) 1.19
Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med (2006) 1.18